A Low-Calorie Diet and Exercise Plan Sent Early-Onset Diabetes Into Remission
Finn's Take· TL;DR- 54% of early-onset type 2 diabetes patients achieved remission through 800-900 calorie diet plus structured exercise, versus 4% in standard care control group.
- Combined low-calorie diet and exercise preserved muscle while burning fat, improved heart structure, and increased strength more effectively than diet alone.
- Long-term remission sustainability uncertain beyond 24 weeks; ongoing weight-maintenance support likely needed to prevent relapse over time.
A Diagnosis That Doesn't Have to Be Permanent
Early-onset type 2 diabetes is a distinct and growing clinical condition marked by rapid deterioration in blood sugar control, early onset of complications, and lower life expectancy than later-onset type 2 diabetes. For the millions of younger adults living with this diagnosis, the conventional wisdom has long been grim: manage it, slow it down, but never expect it to go away. A landmark new study is challenging that assumption in a dramatic way.
New research published in *The Lancet Regional Health Americas* in October 2026 shows that in people who developed early-onset type 2 diabetes before the age of 45, around half of those cases can be reversed with a low-energy diet combined with a structured exercise programme. The findings offer a powerful, medication-free path forward for a population that has historically had very few good options.
What the Trial Actually Looked Like
The RESET for Remission trial included 96 adults aged 18 to 45 years diagnosed with type 2 diabetes within the previous six years, with a mean age of 38 years and 47% women. One group received standard care, while the other followed a low-calorie diet of 800–900 calories a day alongside a structured exercise programme for 12 weeks, followed by a healthy weight-maintenance plan and continued exercise for another 12 weeks.
Participants in the diet and exercise group stopped taking their diabetes and blood pressure medication where appropriate and followed a meal-replacement programme for the first two weeks. For the next 10 weeks, they continued the low-calorie diet but were allowed one regular meal a day, including protein, fruit, and vegetables. Exercise consisted of two supervised sessions and one independent session each week. The combination was intentional: researchers wanted to tackle both blood sugar and body composition at the same time.
The Results Were Striking
Remission at 24 weeks occurred in 27 of 50 intervention participants (54%) versus just 2 of 46 control participants (4%) — with statistical analysis showing that those in the intervention group were 21 times more likely to achieve remission than those in the control group. Remission was defined as having a blood sugar level below the diabetes threshold and not taking any diabetes medication for at least 12 weeks.
Much of this difference may have been due to weight loss: people in the intervention arm lost 18.5 pounds on average, compared to just 2.6 pounds for those in the control arm. But the benefits went well beyond the scale. The intervention also led to fat loss with preservation of fat-free mass and muscle volume, greater handgrip strength, and increased fitness relative to body mass. The structure of the heart was also positively changed.
Why This Matters Beyond the Study
Weight loss driven by lower energy intake alone is associated with reductions in both fat and fat-free mass, and there is some evidence that weight regain may preferentially restore fat over fat-free mass, resulting in a net loss of fat-free mass and an increased risk of muscle loss over time. The addition of resistance and aerobic exercise appears to be the key ingredient that protects against that outcome — making this combination more effective than dieting alone.
Evidence from longer diet-based remission studies suggests that remission can persist for some participants, although rates decline over time and ongoing support for weight-loss maintenance is likely important. That caveat is worth keeping in mind — this trial measured outcomes at 24 weeks, and researchers acknowledge that sustaining remission over the long term will require continued effort. Still, the implications are significant. For a younger generation increasingly diagnosed with a disease once associated mainly with older adults, a structured, non-pharmaceutical intervention that produces remission in more than half of participants represents a genuine turning point in how early-onset type 2 diabetes might be treated.